Stephen Squinto Net Worth & Insider Trades
Stephen Squinto - EVP, Alexion Pharmaceuticals Inc
What is Stephen Squinto's Net Worth?
The current estimated net worth of Alexion Pharmaceuticals Inc's EVP, Stephen Squinto, is estimated to be about $274.04M . Stephen Squinto owns about 106,508 units of Alexion Pharmaceuticals Inc common stock. In the last 11 years at Alexion Pharmaceuticals Inc, Stephen Squinto has sold an estimated value of $77.42M worth.
What is Stephen Squinto's Past Insider Trading?
Stephen Squinto's largest purchase order was 40,037 units , worth over $3.27M on October 30, 2013. Stephen Squinto's largest sale order was 101,683 units , worth over $10.91M on July 31, 2012. In total, Stephen Squinto has made about 73 transactions over 11 years of their time at Alexion Pharmaceuticals Inc. Stephen Squinto usually trades in January, with the busiest year in 2013. The most recent transaction was a sale order of 5,910 units , worth over $1.11M on October 28, 2014.
STEPHEN SQUINTO
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Stephen Squinto's' Mailing Address?
- Mailing address is C/o Alexion Pharmaceuticals Inc 352 Knotter Drive Cheshire CT 06410 CT
Alexion Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Ludwig Hantson | 2019 | $1,250,000 | - | $15,243,634 | - | $2,430,000 | $24,350 | $18,947,984 |
| Ludwig Hantson | 2018 | $1,200,000 | - | $12,385,168 | - | $2,880,000 | $25,082 | $16,490,250 |
| Ludwig Hantson | 2017 | $900,000 | - | $9,618,758 | $2,282,881 | $2,275,000 | $233,428 | $15,310,067 |
| Aradhana Sarin | 2019 | $651,764 | - | $3,380,763 | - | $813,011 | $31,604 | $4,877,142 |
| Paul Clancy | 2019 | $927,000 | - | $3,863,694 | - | $1,051,218 | $23,832 | $5,865,744 |
| Paul Clancy | 2018 | $900,000 | - | $3,302,761 | - | $1,260,000 | $23,752 | $5,486,513 |
| Paul Clancy | 2017 | $415,385 | $500,000 | $8,799,954 | $1,220,082 | $473,620 | $2,262 | $11,411,303 |
| Brian Goff | 2019 | $740,000 | - | $3,863,694 | - | $923,076 | $20,240 | $5,547,010 |
| Brian Goff | 2018 | $695,250 | - | $3,096,323 | - | $973,350 | $111,873 | $4,876,796 |
| Brian Goff | 2017 | $381,634 | $100,000 | $2,390,026 | $732,899 | $434,380 | $58,787 | $4,097,726 |
| Anne-Marie Law | 2019 | $695,000 | - | $3,622,303 | - | $788,130 | $33,528 | $5,138,961 |
| Anne-Marie Law | 2018 | $650,000 | - | $2,889,885 | - | $910,000 | $846,604 | $5,296,489 |
| Anne-Marie Law | 2017 | $362,500 | $200,000 | $2,300,015 | - | $410,472 | $68,710 | $3,341,697 |
| John Orloff | 2019 | $770,000 | - | $3,863,694 | - | $960,498 | $32,550 | $5,626,742 |
| John Orloff | 2018 | $695,250 | - | $3,096,323 | - | $973,350 | $98,679 | $4,863,602 |
| John Orloff | 2017 | $376,442 | $200,000 | $2,499,995 | - | $472,500 | $80,351 | $3,629,288 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/899866/000089986620000032/a2020proxy.htm
What are Alexion Pharmaceuticals Inc's Past Insider Trades?
Alexion Pharmaceuticals Inc's most recent insider trade came on December 21, 2020 by Daniel Bazarko who sold 24,066 units worth $3.8M . In the last 17 years, insiders at Alexion Pharmaceuticals Inc have sold an estimated value of $1.09B and bought an estimated value of $426.64M worth of shares. Insider trading is most common in February, with the busiest year in 2014. The most active traders at the company are Leonard Bell, Director, Stephen Squinto, EVP, and Vikas Sinha, EVP & CFO .
ALEXION PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||